ANN ARBOR, Mich., Feb. 27, 2020 /PRNewswire-PRWeb/ — RXA, the leader in applied artificial intelligence, advanced data science, and analytics allowing companies to make smarter, faster decisions, today announced two new additions to the executive leadership team to support its exponential growth. Heather Reed has been appointed RXA’s Chief Experience Officer, and Jeff Doak will assume the role of Chief Technology Officer.

Chief Technology Officer Jeff Doak will lend structure to RXA as it expands technology programs and addresses further growth of artificial intelligence and machine learning. This new appointment ensures that RXA will remain ahead of the curve in technology adoption and usage. As Chief Experience Officer, Heather Reed will oversee client relations, ensuring all clients have the best possible experience with RXA’s products and services. In this position, Heather will certify that RXA has the highest client retention and loyalty.

Heather has dedicated her career to guiding organizations on how best to connect with their customers, largely focused on market research management consulting across industries and disciplines. Heather has built and led large delivery teams charged with creating roadmaps for organizations to take action to improve the customer and employee experience, while optimizing resources. She also has extensive experience in organizational restructuring, operations and international acquisitions. Heather holds an MBA from the University of Michigan Ross School of Business.

“The industry is experiencing exponential growth in the area of advanced technology and Heather’s leadership and expertise as our new Chief Experience Officer are critical to what customers need and want in a trusted advisor. She understands the market and her leadership is unmatched in the industry,” said Tom Stanek, president RXA. “We look to Heather to continue to cultivate our culture of meaningful, client-driven results while orchestrating the best possible customer experience, whether that be with our people, products, services, or our marketing efforts.”

“Heather has become an indispensable partner for us,” said Jose Clemente, AISIN. “We have been able to achieve maturity under her leadership – overseeing and now moving forward with tangible results.”

Jeff Doak has been a leader in data analytics and visualization for over 20 years. His skills as a data engineer and developer have helped hundreds of companies find meaningful insights across a variety of digital practices. At RXA, he has managed the data engineering practice of the business, ensuring clients’ data assets provide timely, meaningful insights. Jeff was formally CTO of Converseon, a technology, AI, and machine learning company, where he oversaw the development of industry leading technologies and tools.

“Jeff’s extensive knowledge about information technology and data analysis is part of the reason our technical division has grown substantially in recent years. We are thrilled to be able to offer him a new title and greater responsibility at our company,” said Jonathan Prantner, Chief Analytics Officer, RXA. “With these two additions to the leadership team, I feel every confidence that RXA will impact the AI space locally and across the globe.”

About RXA
RXA is a leading applied artificial intelligence and data science company founded in 2016 in Ann Arbor, MI. RXA has a diverse portfolio of services and solutions such as being a leading DOMO implementation and consulting firm, customized artificial intelligence kick-start programs, and an RXA Studio to support the development of new products, companies, and proprietary solutions such as Media Optimization, Voice of Customer, and Workforce Optimization to help organizations improved their ROI and decision making while streamline operations.

RXA’s solutions are currently being leveraged by over 70 different customers across North America, Europe, and Asia. RXA has been named the 2019 Innovative Partner of the Year by Domo, Inc.

Website: http://www.rxa.io
Twitter: @RXAio
LinkedIn: company/rxa.io

SOURCE RXA